Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Measuring Cocaine Withdrawal

Key Clinical Context

  • The American Academy of Pediatrics states that an abstinence syndrome after intrauterine exposure to central nervous system (CNS) stimulants such as cocaine has not been clearly defined, and cocaine withdrawal differs substantially from opioid withdrawal 1, 2

Why Traditional Withdrawal Scales Don't Apply

  • Opioid-based scales are inappropriate for cocaine, as they do not capture the unique neurobehavioral profile of cocaine, according to the American Academy of Pediatrics 1, 2
  • The modified Finnegan's Neonatal Abstinence Scoring System was designed and validated for opioid withdrawal, not stimulant withdrawal, as noted by the American Academy of Pediatrics 3

What to Measure Instead: Craving and Neurobehavioral Symptoms

  • The Tiffany Cocaine Craving Inventory is recommended for measuring cocaine craving in research and clinical settings, with strong evidence from the field of neuroscience 4, 5
  • Visual Analogue Scales (VAS) have face validity but limited content and predictive validity for the complex, multifaceted aspects of craving, according to the American Academy of Pediatrics 4, 5
  • Common neurobehavioral abnormalities in cocaine-exposed individuals include irritability, hyperactivity, tremors, high-pitched cry, excessive sucking, anxiety, and agitation, as reported by the American Academy of Pediatrics 1, 2, 4

Clinical Pitfall to Avoid

  • The American Academy of Pediatrics recommends not attributing clinical signs solely to cocaine withdrawal based on positive drug history alone, and always performing careful assessment to exclude other causes such as infection, sepsis, or acute toxicity 1, 2, 3

Practical Approach

  • The American Academy of Pediatrics suggests using craving scales (such as the Tiffany Cocaine Craving Inventory) combined with systematic assessment of mood, anxiety, irritability, and sleep disturbances for clinical monitoring, rather than attempting to apply opioid withdrawal scales 4, 5